CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients

NCT05061654 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Administrative constraints

Conditions

Interventions

Sponsor

Hamad Medical Corporation

Collaborators